Navigation Links
Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
Date:5/24/2011

010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.

References

  1. So A, Alten R, Bardin T, et al. Canakinumab vs triamcinolone in the treatment of acute flares in gouty arthritis patients contraindicated, intolerant and unresponsive to NSAIDs and/or colchicine. Abstract (EULAR11-2483) at: The 2011 Annual European Congress of The European League Against Rheumatism; 2011 May 25-28; London, United Kingdom.
  2. Schlesinger N, Alten R, Bardin T, et al. Efficacy of canakinumab vs triamcinolone acetonide in preventing recurrent flares in acute gouty arthritis patients contraindicated, intolerant or unresponsive to NSAIDs and/or colchicine. Oral presentation (OP0107) at: The 2011 Annual European Congress of The European League Against Rheumatism; 2011 May 25-28; London, United Kingdom.
  3. Schumacher HR Jr. The pathogenesis of gout. Cleve Clin J Med. 2008; 75(5):S2-4.
  4. Annemans l, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008; 67(7):960-6.
  5. Zhu Y, Pandya B, Choi H. Increasing gout prevalence in the US over the last two decades: The National Health and Nutrition Examination Survey (NHANES). Presented at: The American College of Rheumatology Annual Scientific Meeting; 2010 Oct; Atlanta, GA.
  6. Myasoedova E, Crowso
    '/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014  Life Science Angels (LSA), a ... promising emerging biotech, medical device, genomics, diagnostic and ... Angel Investment Group in the U.S.  LSA was ... out of 370 angel groups analyzed nationwide based ... (connections), selection aptitude and brand recognition.  LSA was ...
(Date:9/30/2014)... Headquartered in Anaheim, California ... comprised of several specialized partners focused on leveraging the ... expertise of its team of professionals to improve the ... of more than 10 professional diagnostic tests for hospitals, ... 8 retail consumer tests is proud to announce an ...
(Date:9/30/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... a finalist in the Diagnostics & Research Tools ... Awards, sponsored by CONNECT. CONNECT, a regional program that ... sciences products in San Diego County ...
Breaking Medicine Technology:Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3WholeHealth Products Announces The Discovery Of The "Autism And Fragile X" Microwell And Rapid Diagnostic Test 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3
... every clinical laboratory possesses one essential devicea centrifuge. ... refrigerated or non-cooled, but this apparatus, because of ... creating spin-induced high g-forces, has long been a ... For all this utility, these machines are true ...
... (EBV), which causes infectious mononucleosis (IM), is one of ... most people become infected with EBV sometime during their ... percent of adults between 35 and 40 years of ... the U.S., infection with EBV most often occurs during ...
Cached Medicine Technology:Bench-Top Centrifuges--Basic Tools for the Small Lab 2Bench-Top Centrifuges--Basic Tools for the Small Lab 3Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 2Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 3
(Date:9/30/2014)... 30, 2014 Sheridan Healthcare, ... the nation, today announced that Adam Blomberg, MD, ... division, will present at the Society for Healthcare ... Connections 2014 . The conference will be held ... Connections is a four-day conference that draws in ...
(Date:9/30/2014)... Visit Pam and Steve’s quiet home in the ... a loving couple facing the most monumental challenge of ... Steve was diagnosed with ALS – more commonly known ... the couple’s second wedding anniversary. Pam is now ... “Care, Support & ALS,” that’s part of the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Houstonians seeking ... a place to visit on the Internet. Paul ... Houston’s most respected cosmetic surgeons, has launched a new ... the benefits of Botox Cosmetic services. The ... , According to the new website, Botox Cosmetic ...
(Date:9/30/2014)... Edward D. Buckingham, M.D., owner of the Buckingham ... be a director of a fellowship for the American ... program. The announcement came last week from the AAFPRS ... and Research Foundation for the AAFPRS fellowship program is ... postgraduate program in the world for the training of ...
(Date:9/30/2014)... TrailMyx.com —the country’s leading purveyor of ... Month: raw pumpkin seeds. , Pumpkin seeds—also known as ... protein, and valued by experts as an excellent source ... E. They are prized for their contributions to bone ... , Of course, pumpkin seeds are closely associated with ...
Breaking Medicine News(10 mins):Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 2Health News:Sheridan Healthcare Anesthesiologist to Present at Society for Healthcare Strategy & Market Development Conference 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 3Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:TrailMyx.com Features October Flavor of the Month 2
... which is set to appear online later in ... the possible implications for traumatic brain injury (TBI) ... anti-inflammatory drugs (NSAIDS) as ibuprofen for chronic pain. ... humans have shown that long-term use of ibuprofen ...
... Children's Research Hospital it was found that a gene responsible ... also initiate leukemias. // ,This gene results in leukemia ... The discovery of the normal function of this gene suggests ... form might be used in leukemia patients with few serious ...
... certain genetic variation, along with inflammatory factors and smoking, ... macular degeneration, according to a study.// ,Age-related macular ... visual loss in the elderly of the Western world, ... play a role in AMD, and inflammation also may ...
... British schools are concerned that children in primary schools ... schools to tackle inappropriate// sexual behaviour. ,Children ... other in a rather "sexualised" manner with games such ... enough not to set alarm bells ringing. ...
... relied on humid air to relieve the barking cough and ... sends worried families to the emergency room. Now a new ... little medical benefit. ,“Typically you get people to ... you get them to boil a kettle in the room, ...
... that the elderly should not be barred from stroke rehabilitation ... the older a stroke victim, the less are the chances ... people over 80 years of age can recover as much ... the researchers studied 878 stroke survivors who received rehabilitation in ...
Cached Medicine News:Health News:Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 3Health News:Genetic Variation Linked to Age-Related Macular Degeneration 2Health News:Humid Air is Little Help for Croup's Barking Cough 2Health News:Humid Air is Little Help for Croup's Barking Cough 3